Last checked at 9 Feb 2021 09:31
BROKER RATINGS: HSBC And ASOS Raised, DS Smith And Spire Cut
BROKER RATINGS: HSBC And ASOS Raised, DS Smith And Spire Cut
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades6,138
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,653.00
Bid:
1,654.00
Ask:
1,654.50
Change:
12.50 (0.76%)
Spread:
0.50 (0.03%)
Open:
1,638.50
High:
1,655.50
Low:
1,634.00
Prev. Close:
1,640.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.8 Feb 2021 14:17
TOP NEWS: GlaxoSmithKline Notes EU Approval For HIV Drug Rukobia
TOP NEWS: GlaxoSmithKline Notes EU Approval For HIV Drug Rukobia
Read more8 Feb 2021 09:35
BROKER RATINGS: Flutter Raised To Buy; Fresnillo Lowered To Sell
BROKER RATINGS: Flutter Raised To Buy; Fresnillo Lowered To Sell
Read more7 Feb 2021 10:46
UPDATE 2-UK says COVID-19 booster and annual vaccinations very probable
* Minister expects annual vaccinations may be needed* Govt not planning vaccine passports -Nadhim Zahawi* UK reports a further 15,845 cases, 373 deaths (Adds latest figures, line on vaccine passports)By Costas PitasLONDON, Feb 7 (Reuters) - A COVID-...
Read more7 Feb 2021 10:46
UPDATE 1-UK says COVID-19 booster and annual vaccinations very probable
(Adds details)LONDON, Feb 7 (Reuters) - A COVID-19 booster in the autumn and then annual vaccinations are very probable, Britain's vaccine deployment minister said on Sunday as countries race to administer injections in the face of new variants.Br...
Read more7 Feb 2021 09:53
UK eyes COVID-19 booster in autumn, then annual vaccinations, says minister
LONDON, Feb 7 (Reuters) - A COVID-19 booster and annual vaccinations are very probable, vaccine deployment minister Nadhim Zahawi said on Sunday as countries race to administer jabs in the face of new variants."We see very much probably an annual ...
Read more5 Feb 2021 13:27
Friday broker round-up
(Sharecast News) - Burberry: Goldman Sachs upgrades to neutral with a target price of 1,690p.
Read more5 Feb 2021 12:30
CureVac To Work With UK Government On Vaccines For Covid Variants
CureVac To Work With UK Government On Vaccines For Covid Variants
Read more4 Feb 2021 15:54
Deutsche Bank cuts GlaxoSmithKline to 'sell', says valuation alone is not enough
(Sharecast News) - Analysts at Deutsche Bank downgraded their recommendation for shares of GlaxoSmithKline to "sell" following the UK drug giant's latest quarterly update.
Read more4 Feb 2021 12:55
Thursday broker round-up
(Sharecast News) - GSK: Deutsche Bank downgrades to sell with a target price of 1,150p.
Read more4 Feb 2021 09:27
BROKER RATINGS: GlaxoSmithKline Gets Two Downgrades; Prudential Raised
BROKER RATINGS: GlaxoSmithKline Gets Two Downgrades; Prudential Raised
Read more4 Feb 2021 08:21
LONDON BRIEFING: Newly Unified Unilever Sets Out Growth Ambitions
LONDON BRIEFING: Newly Unified Unilever Sets Out Growth Ambitions
Read more3 Feb 2021 16:58
LONDON MARKET CLOSE: Rising Oil Majors Help Offset Sinking Glaxo
LONDON MARKET CLOSE: Rising Oil Majors Help Offset Sinking Glaxo
Read more3 Feb 2021 12:24
UPDATE 3-GSK sees lower profit as COVID-19 disruptions drag on
* Sees mid-to-high single digit fall in 2021 earnings* Pressured by COVID-19 disruptions, investment* Split into two companies on track* Shares fall as much as 5% (Adds CEO comments from media call, link to breakingviews)By Pushkala Aripaka and Ludw...
Read more3 Feb 2021 12:24
UPDATE 2-GSK sees lower profit this year as COVID-19 disruptions drag on
* Sees mid-to-high single digit fall in 2021 earnings* Pressured by COVID-19 disruptions, investment* Split into two companies on track* Shares fall around 3% (Adds detail, background)By Pushkala Aripaka and Ludwig BurgerFeb 3 (Reuters) - GSK warned...
Read more